EFFICACY AND SAFETY OF CHEMOTHERAPY CONTAINING BEVACIZUMAB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION

被引：0
|
作者：
Fujii, Mitsuhiro [1 ]
Iwakami, Shin-Ichiro [1 ]
Ihara, Hiroaki [1 ]
Hara, Munechika [1 ]
Iwakami, Naoko [1 ]
Ishiwata, Toshiji [1 ]
Takahashi, Kazuhisa [2 ]
机构：
[1] Juntendo Univ, Shizuoka Hosp, Dept Resp Med, Shizuoka, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
RESPIROLOGY | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [31] Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion
    Li, Tianyuan
    Tian, Panwen
    Huang, Qin
    Zeng, Hao
    Wei, Qi
    Li, Yalun
    CLINICAL RESPIRATORY JOURNAL, 2023, 17 (11): : 1158 - 1168
  • [32] Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control
    Hsu, I-Lin
    Su, Wu-Chou
    Yan, Jing-Jou
    Chang, Jia-Ming
    Lai, Wu-Wei
    LUNG CANCER, 2009, 65 (03) : 371 - 376
  • [33] Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)
    Noro, R.
    Kobayashi, K.
    Usuki, J.
    Hosomi, Y.
    Nishitsuji, M.
    Okamoto, H.
    Ando, M.
    Hino, M.
    Hagiwara, K.
    Miyanaga, A.
    Seike, M.
    Kubota, K.
    Gemma, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] A phase II study of bevacizumab in non-squamous, non-small-cell lung cancer patients with malignant pleural effusion
    Wu Di
    Cong Yue
    Zhang Ziran
    Zhang Jie
    Nie Jun
    Dai Ling
    Hu Weiheng
    Chen Xiaoling
    Ma Xiangjuan
    Tian Guangming
    Han Jindi
    Han Sen
    Wang Yang
    Long Jieran
    Fang Jian
    FUTURE ONCOLOGY, 2022, 18 (06) : 669 - 677
  • [35] Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases
    Takaaki Tokito
    Takehito Shukuya
    Hiroaki Akamatsu
    Tetsuhiko Taira
    Akira Ono
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Toshiaki Takahashi
    Masahiro Endo
    Nobuyuki Yamamoto
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1493 - 1498
  • [36] Efficacy of bevacizumab-containing chemotherapy for non-squamous non-small cell lung cancer with bone metastases
    Tokito, Takaaki
    Shukuya, Takehito
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1493 - 1498
  • [37] MID-TERM RESULTS OF INTRAPLEURAL PERFUSION HYPERTHERMIC CHEMOTHERAPY FOR THE PATIENTS WITH MALIGNANT PLEURAL SEEDING AND EFFUSION IN NON-SMALL CELL LUNG CANCER
    Yang, Hee Chul
    Park, Eoksung
    Sim, Eunee
    Lee, Jung-Moon
    Sung, S. -W.
    Jheon, Sanghoon
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1303 - S1303
  • [38] Prognostic Significance of Minimal Pleural Effusion in Non-small Cell Lung Cancer Patients
    Ryu, Jeong Seon
    Ryu, Hyo-Jin
    Nam, Hae-Seong
    Kim, Hyun-Jung
    CHEST, 2013, 144 (04)
  • [39] Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer
    Wang, Junjun
    Ling, Liqun
    Chen, Shuhui
    Chou, Lunan
    Wang, Yumin
    Hu, Lijuan
    LABORATORY MEDICINE, 2024, 55 (03) : 271 - 276
  • [40] SIGNIFICANCE OF MINIMAL PLEURAL EFFUSION IN NON-SMALL CELL LUNG CANCER
    Martin, G. A.
    Tsim, S.
    MacLay, J.
    Stewart, C.
    Blyth, K. G.
    THORAX, 2016, 71 : A86 - A86
12345